Scientists believe diabetics will one day replace daily injections with an implanted shock wave container of cells that produce insulin therapy naturally, writes Sean Hargrave. Animal tests on the new technique have recently been set up by BetaGene, a Texan biomedical company. If successful, the company will begin human clinical trials, although it warns that a marketable treatment is years away.